Published in J Neural Transm on January 01, 1989
Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells. J Neural Transm (Vienna) (1997) 0.82
Quantification of salsolinol enantiomers by stable isotope dilution liquid chromatography with tandem mass spectrometric detection. Rapid Commun Mass Spectrom (2008) 0.78
Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system. Neurotox Res (2014) 0.75
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature (1997) 5.47
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev (2001) 2.07
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci (2000) 1.83
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Brain (2008) 1.70
Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology (2010) 1.60
Study of physiological availability of temazepam in man. Int J Clin Pharmacol (1972) 1.49
Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. J Mol Biol (2001) 1.39
Plasma ferritin determination as a diagnostic tool. West J Med (1986) 1.34
Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int J Androl (1999) 1.27
Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet (2000) 1.27
High frequency of well-defined Y-chromosome deletions in idiopathic Sertoli cell-only syndrome. Hum Reprod (1998) 1.20
Deep brain stimulation in the treatment of severe dystonia. J Neurol (2001) 1.19
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J Biol Chem (2001) 1.19
Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology (2007) 1.14
Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women. Cancer Res (1992) 1.11
Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies. Environ Health Perspect (1994) 1.11
Reduced binding of 3 H-reserpine to the hearts of 6-hydroxydopamine-pretreated rats. Eur J Pharmacol (1972) 1.10
Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis (2013) 1.08
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci U S A (1995) 1.08
The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol (1999) 1.07
ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther (1997) 1.05
Human male infertility and Y chromosome deletions: role of the AZF-candidate genes DAZ, RBM and DFFRY. Hum Reprod (1999) 1.04
The human Y chromosome's azoospermia factor b (AZFb) region: sequence, structure, and deletion analysis in infertile men. J Med Genet (2003) 1.04
Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. Histol Histopathol (2000) 1.04
Zolpidem in progressive supranuclear palsy. N Engl J Med (1999) 1.02
Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00
Absorption, disposition and preliminary metabolic pathway of 14C-rifabutin in animals and man. J Antimicrob Chemother (1990) 1.00
Pallidal deep brain stimulation in cervical dystonia: clinical outcome in four cases. Can J Neurol Sci (2004) 0.99
Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain (2010) 0.98
Prognostic value of Y deletion analysis. The role of current methods. Hum Reprod (2001) 0.98
Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology (2002) 0.98
Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes. Chem Biol Interact (1999) 0.97
Determination of ethambutol in human plasma and urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr A (1996) 0.97
Y chromosome microdeletions in cryptorchidism and idiopathic infertility. J Clin Endocrinol Metab (1999) 0.96
A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line. Cancer Res (2001) 0.96
Synthesis and anticonvulsant activity of a new class of 2-[(arylalky)amino]alkanamide derivatives. J Med Chem (1998) 0.95
Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin. Cancer Res (2001) 0.95
Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD. Parkinsonism Relat Disord (2012) 0.95
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils. Eur J Biochem (1997) 0.95
Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. Neurology (2000) 0.95
Autoinduction of rifabutin metabolism in man. Xenobiotica (1990) 0.93
Limited proteolysis in the investigation of beta2-microglobulin amyloidogenic and fibrillar states. Biochim Biophys Acta (2005) 0.93
New drug therapy of amyloidoses: resorption of AL-type deposits with 4'-iodo-4'-deoxydoxorubicin. Blood (1995) 0.92
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. Am J Hematol (1994) 0.92
Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity. J Med Chem (2001) 0.92
Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease. Neurology (2007) 0.91
Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver. J Antimicrob Chemother (1996) 0.89
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. Protein Sci (2001) 0.89
Fate of the analgesic and anti-inflammatory drug K 4277 after oral administration to man. Eur J Clin Pharmacol (1973) 0.89
Interobserver and echo-angio variability of two-dimensional colour Doppler evaluation of aortic and mitral regurgitation. Eur Heart J (1989) 0.89
Multisensory determinants of orientation perception in Parkinson's disease. Neuroscience (2010) 0.89
Developmental aspects of the monoamine-degrading enzyme monoamine oxidase. Dev Pharmacol Ther (1992) 0.89
Feasibility and variability of six methods for the echocardiographic and Doppler determination of cardiac output. Br Heart J (1988) 0.88
Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors. Ann Oncol (2006) 0.88
A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol. Neurosci Lett (1996) 0.88
Detection of fragments of beta2-microglobulin in amyloid fibrils. Kidney Int (2000) 0.88
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. Am Heart J (1995) 0.87
beta2-microglobulin H31Y variant 3D structure highlights the protein natural propensity towards intermolecular aggregation. J Mol Biol (2004) 0.86
Bioavailability and pharmacokinetics in man of acipimox, a new antilipolytic and hypolipemic agent. J Int Med Res (1981) 0.86
Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT). Br J Cancer (2003) 0.86
Monoamine oxidase, brain ageing and degenerative diseases. Biochem Pharmacol (1989) 0.86
Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology (2004) 0.85
Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. Eur Neurol (1996) 0.85
Enantio-selective occurrence of (S)-tetrahydropapaveroline in human brain. Neurosci Lett (2000) 0.85
Occurrence of monoclonal components in general practice: clinical implications. Eur J Haematol (1992) 0.85
Radioimmunoassay of acipimox in human plasma and urine. Pharmacol Res Commun (1984) 0.84
Reduced paired pulse depression in the basal ganglia of dystonia patients. Neurobiol Dis (2012) 0.84
Pharmacokinetic studies of indoprofen in healthy volunteers and in patients. Int J Clin Pharmacol Biopharm (1977) 0.84
Molecular mechanisms of fibrillogenesis and the protective role of amyloid P component: two possible avenues for therapy. Ciba Found Symp (1996) 0.84
Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man. Eur J Clin Pharmacol (1979) 0.84
[Biochemical mechanisms of the hepatotoxicity of psychotropic drugs]. Encephale (1984) 0.83
Changes in cortical excitability with thalamic deep brain stimulation. Neurology (2005) 0.83
Pharmacokinetics of the enantiomers of indoprofen in man. Int J Clin Pharmacol Res (1984) 0.83
Subthalamic nucleus stimulation in tremor dominant parkinsonian patients with previous thalamic surgery. J Neurol Neurosurg Psychiatry (2005) 0.83
Experience with the preclinical assessment of basic fibroblast growth factor (bFGF). Toxicol Lett (1992) 0.82
Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid. J Neural Transm (Vienna) (1996) 0.82
Y-chromosomal DNA haplotypes in infertile European males carrying Y-microdeletions. J Endocrinol Invest (2000) 0.82
Immunological reactivity of serum ferritin in patients with malignancy. Tumori (1985) 0.82
Role of the AZFa candidate genes in male infertility. J Endocrinol Invest (2000) 0.82
Urinary metabolites of 14C-labelled FCE 22101 in animals. J Antimicrob Chemother (1989) 0.82
Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells. J Neural Transm (Vienna) (1997) 0.82
An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells. J Neurochem (1997) 0.82
Assay for the (R)- and (S)-enantiomers of salsolinols in biological samples and foods with ion-pair high-performance liquid chromatography using beta-cyclodextrin as a chiral mobile phase additive. J Chromatogr B Biomed Sci Appl (1997) 0.82
Role of acetyl-L-carnitine in rat brain lipogenesis: implications for polyunsaturated fatty acid biosynthesis. J Neurochem (1998) 0.82
Plasma and synovial fluid pharmacokinetics and prostaglandin inhibitory effect of indoprofen in patients with rheumatoid arthritis. Scand J Rheumatol (1980) 0.82
Gastrosparing effect of new antiinflammatory drug amtolmetin guacyl in the rat: involvement of nitric oxide. Dig Dis Sci (1999) 0.81
Absence of testicular DAZ gene expression in idiopathic severe testiculopathies. Hum Reprod (1999) 0.81
A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in Parkinsonian cerebrospinal fluid. Ann Neurol (1996) 0.81
Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization. Clin Exp Allergy (2008) 0.81
Mechanism of enantioseparation of salsolinols, endogenous neurotoxins in human brain, with ion-pair chromatography using beta-cyclodextrin as a mobile phase additive. Anal Chem (1996) 0.81
Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J Neural Transm Gen Sect (1994) 0.81
4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid. Am J Pathol (2000) 0.81
Stereoselective and species-dependent kinetics of reboxetine in mouse and rat. Chirality (1995) 0.81
N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease. J Neural Transm Suppl (1997) 0.81
Correlation of anti-inflammatory activity with inhibition of prostaglandin synthesis activity of nonsteroidal anti-estrogens and estrogens (38532). Proc Soc Exp Biol Med (1975) 0.81